INTELLIGENT BIO SOLUTIONS INC. Proceeds from Warrant Exercises
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Proceeds from Warrant Exercises of $7.94 thousand for the 12-month period ending 2025-06-30, per its 10-K filed 2025-08-15.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromWarrantExercises · last filed 2025-08-15
- INTELLIGENT BIO SOLUTIONS INC. proceeds from warrant exercises for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. proceeds from warrant exercises for the quarter ending 2025-03-31 was $0.00.
- INTELLIGENT BIO SOLUTIONS INC. proceeds from warrant exercises for the quarter ending 2024-12-31 was $0.00.
- INTELLIGENT BIO SOLUTIONS INC. proceeds from warrant exercises for the quarter ending 2024-09-30 was $7.94K.
- INTELLIGENT BIO SOLUTIONS INC. proceeds from warrant exercises for fiscal 2025 was $7.94K, a 99.52% decline from fiscal 2024.
- INTELLIGENT BIO SOLUTIONS INC. proceeds from warrant exercises for fiscal 2024 was $1.66M.
| Period end | Proceeds from Warrant Exercises 3 month | Proceeds from Warrant Exercises 6 month | Proceeds from Warrant Exercises 9 month | Proceeds from Warrant Exercises 12 month |
|---|---|---|---|---|
| 2025-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-15 | $0.00 derived: sum of 2 quarters · filed 2025-08-15 | $0.00 derived: sum of 3 quarters · filed 2025-08-15 | $7.94K 10-K · filed 2025-08-15 |
| 2025-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-13 | $0.00 derived: sum of 2 quarters · filed 2025-05-13 | $7.94K 10-Q · filed 2025-05-13 | $13.25K derived: sum of 4 quarters · filed 2025-08-15 |
| 2024-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-13 | $7.94K 10-Q · filed 2025-02-13 | $13.25K derived: sum of 3 quarters · filed 2025-08-15 | |
| 2024-09-30 | $7.94K 10-Q · filed 2024-11-07 | $13.25K derived: sum of 2 quarters · filed 2025-08-15 | ||
| 2024-06-30 | $5.31K derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-15 | $1.66M 10-K · filed 2025-08-15 | ||
| 2024-03-31 | $1.65M 10-Q · filed 2025-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |